Visceral adiposity research
Visceral fat increases after menopause. Tesamorelin clinical research has measured visceral adipose tissue changes in mixed-sex cohorts including post-menopausal women.
Hormone
Tesamorelin
Growth hormone axis
A synthetic analog of growth-hormone-releasing hormone studied for visceral adipose tissue and IGF-1 regulation.
$94.99per vial · research use
Quantity
Up to 50%
Dose
- GH axis research
- Visceral fat studies
- Lipid profile models
For research use only. Not for human consumption.
Women's research notes
What researchers study Tesamorelin for in women
Tesamorelin clinical trials have included female cohorts, with research on visceral adiposity, lipid profiles and cognitive endpoints relevant to mid-life women.
Cognition & GH axis
Trials have examined cognitive endpoints in older adults, including women, in relation to GH/IGF-1 axis modulation.
Lipid profile research
Published cohorts include female participants with measured changes in triglycerides and cholesterol fractions.
Selected literature
- Stanley TL, et al. JAMA 2014 — Tesamorelin and visceral fat
- Baker LD, et al. Arch Neurol 2012 — GHRH and cognitive function in older adults
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
